Xortx Therapeutics Inc
(XRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 11-2009 | 08-2009 | 05-2009 | 02-2009 | 11-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,414 | -17,964 | -25,771 | -16,128 | -47,909 |
| Depreciation Amortization | 22,136 | 16,690 | 11,139 | 5,459 | 54,908 |
| Income taxes - deferred | 3,021 | N/A | 1 | 1 | 16,944 |
| Accounts receivable | 16,164 | -4,487 | 37,813 | 54,394 | -18,552 |
| Accounts payable and accrued liabilities | -14,909 | -5,347 | -35,477 | -44,903 | 15,249 |
| Other Working Capital | 24,920 | 20,035 | 21,337 | 19,466 | -44,604 |
| Other Operating Activity | 4,370 | 13,701 | 136 | -7,961 | 11,134 |
| Operating Cash Flow | $39,288 | $22,628 | $9,178 | $10,328 | $-12,830 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15,453 | -12,404 | -10,055 | -4,606 | -25,763 |
| Investing Cash Flow | $-15,453 | $-12,404 | $-10,055 | $-4,606 | $-25,763 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 87 | 87 | 87 | N/A | 2,044 |
| Common Stock Repurchased | N/A | N/A | N/A | 87 | -6,116 |
| Financing Cash Flow | $87 | $87 | $87 | $87 | $-4,072 |
| Beginning Cash Position | 28,013 | 28,013 | 28,013 | 28,013 | 70,678 |
| End Cash Position | 51,935 | 38,324 | 27,223 | 33,822 | 28,013 |
| Net Cash Flow | $23,922 | $10,311 | $-790 | $5,809 | $-42,665 |
| Free Cash Flow | |||||
| Operating Cash Flow | 39,288 | 22,628 | 9,178 | 10,328 | -12,830 |
| Capital Expenditure | -15,453 | -12,404 | -10,055 | -4,606 | -25,763 |
| Free Cash Flow | 23,835 | 10,224 | -877 | 5,722 | -38,593 |